An observational study in COVID-19 Vaccine Adverse Reaction, sponsored by Ana Belen Rivas Paterna. Completed at 1 site in Spain. Open to participants aged 5 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-17.
Sponsored by Ana Belen Rivas Paterna · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Drug-Related Side Effects and Adverse Reactions with a site in Spain — 6 open to participants now, 8 under way, none of them phase 3. Drug-Related Side Effects and Adverse Reactions · Spain.
Among the 16 studies in Drug-Related Side Effects and Adverse Reactions with a site in Spain, this one is one of 4 that started in 2022, is one of 5 observational ones, and was the 10th registered.
449 studies on the registry are indexed under Drug-Related Side Effects and Adverse Reactions; 77 are open to participants now.
Browse Drug-Related Side Effects and Adverse Reactions studies →6 of the 16 studies in Drug-Related Side Effects and Adverse Reactions with a site in Spain are open now. Recruiting first, the newest first:
Adcytherix SAS · Sites in Spain, Australia
Ages 18+
Eli Lilly and Company · Sites in Spain, United States, Australia and 7 more countries
Ages 18+
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · Sites in Spain
Ages 18+
Parc Sanitari Pere Virgili · Sites in Spain
Ages 65+
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León · Sites in Spain
Ages 65+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 56 Drug-Related Side Effects and Adverse Reactions studies recruiting now, 38 (68%) set no upper age limit and 15 (27%) stop at 75 or younger; 15 take children under 18; 4 take healthy volunteers.
This study: 5 Years to 12 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 1
First in 2001; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 2,100 is above the median of 414 across 162 observational studies indexed under Drug-Related Side Effects and Adverse Reactions.
Median enrollment 290 across the 11 interventional studies, 1,000 across the 5 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 16 have an industry lead sponsor. The 10 most frequent:
Ana Belen Rivas Paterna is the lead sponsor of 2 studies on the registry; none are open to participants now.
Ana Belen Rivas Paterna has 1 study filed under Drug-Related Side Effects and Adverse Reactions — fewer than ten, so there is no comparison to draw.
3 of the studies in Drug-Related Side Effects and Adverse Reactions with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07169851Eli Lilly and CompanyA Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer | 2026-12 |
| NCT07582887Fundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalImpact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response | 2026-12-31 |
| NCT07008144Consorci Sanitari de l'Alt Penedès i GarrafIntroducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 16 studies in Drug-Related Side Effects and Adverse Reactions with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Drugs side effects in children need to be evaluated in a different way because of their constant growth and body changes.
The use of COVID-19 vaccines (mRNA vaccines) is worldwide spread as a safety measure against the pandemic.
Although clinical trials have shown that vaccines are safe in the general population, specific real-life monitoring is needed to address the special situation that applies to children.
Drug-related side effects are an important health problem causing an increase in health costs. Most of the related research is focused on the adult population, therefore evidence in pediatric patients is scarse. This situation remains true in the clinical trials of the mRNA vaccines against COVID-19, with most studies suggesting the need of a greater follow up and specific research that address the pediatric population. Even though vaccines seem to be a safe and effective ways to protect the population against the COVID-19 pandemic, more information is needed regarding the safety profile for pediatrics in the short and long term.
All the pediatric patients (between 5-12 years old) vaccinated in the Clinico San Carlos' Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children between 5 and 12 years old vaccinated with 2 doses of an approved mRNA vaccione against COVID-19.
Biological: mRNA COVID-19 vaccine
Children will be vaccinated according to standard local procedure
Incidence of vaccine side effects
Incidence of vaccine side effects
Time frame: 10 days, 1 month and 6 months after vaccination
Vaccine side effects
Clinical description of side effects that occurre during follow up
Time frame: 10 days, 1 month and 6 months after vaccination
Time to vaccine side effect
Clinical description of side effect according to the time of appearance
Time frame: 10 days, 1 month and 6 months after vaccination
Causality of side effects
Evaluation of the causality by using the modified Karch-Lasagna modified scale
Time frame: 10 days, 1 month and 6 months after vaccination
Severity of side effects
Evaluation of the severity using de Venulet criteria and the spanish pharmacovigilance system
Time frame: 10 days, 1 month and 6 months after vaccination
Vaccine and drug interactions
Evaluation of the possible interaction between the vaccines and regularly prescribed drugs
Time frame: 10 days, 1 month and 6 months after vaccination
Vaccine reactogenicity
Evaluation of the difference reactogenicity between the first and second vaccine dose by recording the side effect appearance after each dose.
Time frame: 10 days, 1 month and 6 months after vaccination
Perceived quality of the vaccination system
Evaluation of the parents perceived quality of the vaccination system
Time frame: 10 days, 1 month and 6 months after vaccination
Plan to share: No — There is not a plan to make IPD available
Ran from Mar 2022 to primary completion in Mar 2023, 11 months.
Of 65 non-industry observational studies under Drug-Related Side Effects and Adverse Reactions, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 24. This study's 11 months is below that.
Counting every sponsor, half of 69 studies reached it within 45 months; a quarter within 24 and three quarters within 97.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Drug-Related Side Effects and Adverse Reactions →
Ana Belen Rivas Paterna